SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, Adam P Dicker, Robert B Den, Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?, Expert Review of Anticancer Therapy, 2014, 14, 1, 39

    CrossRef

  2. 2
    Monica E. Shukla, Changhong Yu, Chandana A. Reddy, Kevin L. Stephans, Eric A. Klein, May Abdel-Wahab, Jay Ciezki, Rahul D. Tendulkar, Evaluation of the Current Prostate Cancer Staging System Based on Cancer-Specific Mortality in the Surveillance, Epidemiology, and End Results Database, Clinical Genitourinary Cancer, 2014,

    CrossRef

  3. 3
    Nicholas G. Zaorsky, Laura A. Doyle, Kosj Yamoah, Jocelyn A. Andrel, Edouard J. Trabulsi, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den, High dose rate brachytherapy boost for prostate cancer: A systematic review, Cancer Treatment Reviews, 2014, 40, 3, 414

    CrossRef

  4. 4
    J.G. Baust, A.A. Gage, T.E. Bjerklund Johansen, J.M. Baust, Mechanisms of cryoablation: Clinical consequences on malignant tumors, Cryobiology, 2014, 68, 1, 1

    CrossRef

  5. 5
    Nicholas G Zaorsky, Robert B Den, Laura A Doyle, Adam P Dicker, Mark D Hurwitz, Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer, Expert Review of Medical Devices, 2013, 10, 6, 751

    CrossRef

  6. 6
    Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den, Evolution of advanced technologies in prostate cancer radiotherapy, Nature Reviews Urology, 2013, 10, 10, 565

    CrossRef